Liquid-liquid phase separation in highly supersaturated aqueous solutions of poorly water-soluble drugs: Implications for solubility enhancing formulations

Crystal Growth and Design

Volumn 13, Issue 4, 2013, Pages 1497-1509

  Ilevbare, Grace A ^a   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMORPHOUS SOLID DISPERSIONS; COLLOID FORMATION; CRYSTALLINE SOLIDS; LIQUID-LIQUID PHASE SEPARATION; METASTABLE REGION; POLY(VINYL PYRROLIDONE); POORLY WATER-SOLUBLE DRUGS; SUPERSATURATED AQUEOUS SOLUTIONS;

DRUG PRODUCTS; PHASE DIAGRAMS; PHASE SEPARATION; PIPE FLOW; SOLUTIONS; SUPERSATURATION;

SOLUBILITY;

EID: 84875776484     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg301679h     Document Type: Article

References (49)

1. Coan, K. E. D.; Shoichet, B. K. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors J. Am. Chem. Soc. 2008, 130, 9606-9612
2. Coan, K. E. D.; Maltby, D. A.; Burlingame, A. L.; Shoichet, B. K. Promiscuous aggregate-based inhibitors promote enzyme unfolding J. Med. Chem. 2009, 52, 2067-2075
3. Feng, B. Y.; Simeonov, A.; Jadhav, A.; Babaoglu, K.; Inglese, J.; Shoichet, B. K.; Austin, C. P. A high-throughput screen for aggregation-based inhibition in a large compound library J. Med. Chem. 2007, 50, 2385-2390
4. Frenkel, Y. V.; Clark, A. D.; Das, K.; Wang, Y.-H.; Lewi, P. J.; Janssen, P. A. J.; Arnold, E. Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability J. Med. Chem. 2005, 48, 1974-1983
5. Pacheco, L. F.; Carmona-Ribeiro, A. M. Effects of synthetic lipids on solubilization and colloid stability of hydrophobic drugs J. Colloid Interface Sci. 2003, 258, 146-154
6. Seidler, J.; McGovern, S. L.; Doman, T. N.; Shoichet, B. K. Identification and prediction of promiscuous aggregating inhibitors among known drugs J. Med. Chem. 2003, 46, 4477-4486
7. Feng, B. Y.; Shelat, A.; Doman, T. N.; Guy, R. K.; Shoichet, B. K. High-throughput assays for promiscuous inhibitors Nat. Chem. Biol. 2005, 3, 146-148
8. Brick, M. C.; Palmer, H. J.; Whitesides, T. H. Formation of colloidal dispersions of organic materials in aqueous media by solvent shifting Langmuir 2003, 19, 6367-6380
9. Aisha, A. F. A.; Ismail, Z.; Abu-Salah, K. M.; Majid, A. M. S. A. Solid dispersions of α-Mangostin Improve its aqueous solubility through self-assembly of nanomicelles J. Pharm. Sci. 2011, 1-11
10. Tachibana, T.; Nakamura, A. A method for preparing an aqueous colloidal dispersions of organic materials by using water-soluble polymers: Dispersion of β-carotene by polyvinylprrolidone Kolloid Z. Z. Polym. 1965, 203, 130-133
11. Tung, H.-H.; Paul, E. L.; Midler, M.; McCauley, J. A. Critical Issues in Crystallization Practice. Crystallization of Organic Compounds: John Wiley & Sons, Inc.: New York, 2008.
12. Lafferrère, L.; Hoff, C.; Veesler, S. Study of liquid-liquid demixing form drug solution J. Cryst. Growth 2004, 269, 550-557
13. Veesler, S.; Lafferrère, L.; Garcia, E.; Hoff, C. Phase Transitions in Supersaturated Drug Solution Org. Process Res. Dev. 2003, 7, 983-989
14. Groen, H.; Roberts, K. J. Nucleation, growth and pseudo-polymorphic behavior of citric acid as monitored in situ by attenuated total reflection fourier transform infrared spectroscopy J. Phys. Chem. B 2001, 105, 10723-10730
15. Maeda, K.; Aoyama, Y.; Fukui, K.; Hirota, S. Novel Phenomenon of crystallization an emulsification of hydrophobic solute in aqueous solution J. Colloid Interface Sci. 2001, 234, 217-222
16. Hsieh, Y.; Ilevbare, G. A.; Van Eerdenbrugh, B.; Box, K.; Sanchez-Felix, M.; Taylor, L. S. pH-induced precipitation behavior of weakly basic compounds: Determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties Pharm. Res. 2012, 20, 2738-2753
17. Konno, H.; Handa, T.; Alonzo, D. E.; Taylor, L. S. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine Eur. J. Pharm. Biopharm. 2008, 20, 493-499
18. Alonzo, D.; Zhang, G.; Zhou, D.; Gao, Y.; Taylor, L. S. Understanding the behavior of amorphous pharmaceutical systems during dissolution Pharm. Res. 2010, 27, 608-618
19. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Solubility advantage of amorphous pharmaceuticals I. A thermordynamic analysis J. Pharm. Sci. 2009, 99, 1254-1264
20. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Solubility advantage of amorphous pharmaceuticals II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals Pharm. Res. 2010, 27, 2704-2714
21. Hoffman, J. D. Thermodynamic driving force in nucleation and growth processes J. Chem. Phys. 1958, 29, 1192-1193
22. Marsac, P. J.; Konno, H.; Taylor, L. S. A comparison of the physical stability of amorphous felodipine and nifedipine systems Pharm. Res. 2006, 23, 2306-2316
23. Baird, J. A.; Van Eerdenbrugh, B.; Taylor, L. S. A classification system to assess the crystallization tendency of organic molecules from undercooled melts J. Pharm. Sci. 2010, 99, 3787-3806
24. Van Eerdenburgh, B.; Baird, J. A.; Taylor, L. S. Crystallization tendency of active pharmaceutical ingredients following rapid solvent-evaporation- classification and comparison with crystallization tendency from undercooled melts J. Pharm. Sci. 2010, 99, 3826-3838
25. Strickley, R. G. Currently marketed oral lipid-based dosage forms: Drug products and excipients.. In Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water Soluble Drugs; Hauss, D., Ed.; CRC Press: Boca Raton, FL, 2007.
26. Ananthapadmanabhan, K. P.; Goddard, E. D.; Turro, N. J.; Kuo, P. L. Fluorescence probes for critical micelle concentration Langmuir 1985, 1, 352-355
27. Zhao, C.-L.; Winnik, M. A. Fluorescence probe techniques used to study micelle formation in water-soluble block copolymers Langmuir 1990, 6, 514-516
28. Pozharskaya, G. I.; Kasapova, N. L.; Skripov, V. P.; Kolpakov, Y. D. The spinodal approximation by the method of scattering in (n-hexane + n-tetradecafluorohexane) J. Chem. Thermodyn. 1984, 16, 267-272
29. Kuldipkumar, A.; Kwon, G. S.; Zhang, G. G. Z. Determining the growth mechanism of tolazamide by induction time measurement Cryst. Growth Des. 2007, 7, 234-242
30. Bonnett, P. E.; Carpenter, K. J.; Dawson, S.; Davey, R. J. Solution crystallization via a submerged liquid-liquid phase boundary: oiling out Chem. Commun. 2003, 698-699
31. Bauer, J.; Spanton, S.; Henry, R.; Quick, J.; Dziki, W.; Porter, W.; Morris, J. Ritonavir: An extraordinary Example of Conformation Polymorphism Pharm. Res. 2001, 18, 859-866
32. Law, D.; Krill, S. L.; Schmitt, E. A.; Fort, J. J.; Qiu, Y.; Wang, W.; Porter, W. R. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions J. Pharm. Sci. 2001, 90, 1015-1025
33. Ilevbare, G. A.; Liu, H.; Edgar, K. J.; Taylor, L. S. Understanding polymer properties important for crystal growth inhibition-Impact of chemically diverse polymers on solution crystal growth of ritonavir Cryst. Growth Des. 2012, 12, 3133-3143
34. Andronis, V.; Yoshioka, M.; Zografi, G. Effects of sorbed water on the crystallization of indomethacin from the amorphous state J. Pharm. Sci. 1997, 86, 346-351
35. a and pH-solubility behavior of an ionizable cycle carbamate, (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1- benzoxain-2-one (DMP 266) Pharm. Dev. Technol. 1996, 1, 91-95
36. Ramulu, G.; Kumar, Y. R.; Vyas, K.; Suryanarayana, M. V.; Mukkanti, K. A new validated liquid chromatographic method for the determination of loratadine and its impurities Sci. Pharm. 2011, 79, 277-291
37. Shoichet, B. K. Interpreting Steep Dose-Response Curves in Early Inhibitor Discovery J. Med. Chem. 2006, 49, 7274-7277
38. Amis, E. J.; Hu, N.; Seery, T. A. P.; Hogen-Esch, T. E.; Yassini, M.; Hwang, F.; Hydrophilic polymers. Associating polymers containing fluorocarbon hydrophobic units. Adv. Chem. 248, 1996, 279-302.
39. Tanford, C. The Hydrophobic Effect: Formation of Micelles and Biological Membranes; John Wiley: New York, 1973.
40. Chen, L.-J.; Lin, S.-Y.; Huang, C.-C.; Chen, E.-M. Temperature dependence of critical micelle concentration of polyoxyethylenated non-ionic surfactants Colloid. Surface. A 1998, 135, 175-181
41. Schick, M. J. Effect of temperature on the critical micelle concentration of nonionic detergents. Thermodynamics of micelle formation J. Phys. Chem. 1963, 67, 1796-1799
42. Flockhart, B. D. The effect of temperature on the critical micelle concentration of some paraffin-chain salts J. Colloid Sci. 1961, 16, 484-492
43. Stead, J. A.; Taylor, H. Some solution properties of certain surface active N-alkylpyridinium Halides I. Effect of temperature on the critical micelle concentrations J. Colloid Interface Sci. 1969, 30, 482-488
44. Kang, K.-H.; Kim, H.-U.; Lim, K.-H. Effect of temperature on critical micelle concentration and thermodynamic potentials of micellization of anionic ammonium dodecyl sulfate and cationic octadecyl trimethyl ammonium chloride Colloid. Surface. A 2001, 189, 113-121
45. Yalkowsky, S. H. Solubility and Solubilization in Aqueous Media; New York: Oxford University Press, 1999.
46. Sandler, S. I. Chemical and engineering thermodynamics, 3 rd ed.; John Wiley and Sons: New York, 1999.
47. Parks, G. S.; Huffman, H. M.; Cattoir, F. R. Studies on glass II. The transition between the glassy and liquid states in the case of glucose J. Phys. Chem. 1928, 31, 1366-1379
48. Parks, G. S.; Snyder, L. J.; Cattoir, F. R. Studies on glass. XI. Some thermodynamic relations of glassy and alpha-crystalline glucose J. Chem. Phys. 1934, 2, 595-598
49. Hancock, B. C.; Parks, M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 2000, 17, 397-404